Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA NABPLAGEM: High Dose Ascorbic Acid + Chemotherapy in Untreated Metastatic Pancreatic Cancer
NCT03410030Phase 2Completed
- Sponsor
- HonorHealth Research Institute
- Start
- Dec 2017
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in pancreatic cancer (PC), sponsored by HonorHealth Research Institute. Started Dec 2017; status: completed.
02
Drugs
ascorbic acid
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03410030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03410030.